Bruxism Clinical Trial
Official title:
24-Month Performance of a Glass-hybrid-restorative in Non-carious Cervical Lesions of Patients With Bruxism: A Split-mouth, Randomized Clinical Trial
Verified date | October 2018 |
Source | Hacettepe University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This is a double blinded, split mouth, randomized clinical study that evaluated the performance of a glass hybrid restorative material in non-carious servical lesions in patients with bruxism. The lesions were restored with glass hybrid restorative (Equia Forte) or nano ceramic composite resin (Ceram-x One). Restorations were evaluated after 24 months according to USPHS criteria and the data were evaluated.
Status | Active, not recruiting |
Enrollment | 25 |
Est. completion date | May 2022 |
Est. primary completion date | June 2018 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 42 Years to 72 Years |
Eligibility |
Inclusion Criteria: - non-hospitalized, healthy patients that were seeking dental treatmen - occlusally contacted teeth Exclusion Criteria: - Patients having intensive medical history - Chronic periodontitis, - high caries activity, - extremely poor oral hygiene, - teeth with restorations, - mobility due to periodontal disease - in contacted with removable prosthetic construction were excluded from the study |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Hacettepe University |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Retention Alpha for at least 90% of the restorations | The primary factor for determining the clinical performance of a restorative material is the retention rate. It represents the survival rates of the restorations after a period of time. According to ADA guidelines, a restorative material should show at leat 90% alpha retention rate after 18 months to be considered as clinically acceptable. The retention is assesed as alpha (retentive restoratation) or charlie (failed restoration). Clinical evaluation is performed to examine if the restoration is in place or has fallen. | 24 months | |
Secondary | marginal adaptation score alpha | It represents the marginal integrity of the restorations. It is scored as alpha (perfect marginal adaptation), bravo (detectable marginal discrepency, clinically acceptable) or charlie (marginal crevice, clinically unacceptable). The examination of marginal adaptation is performed by clinical examination of the restoration with probe. | 24 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05760482 -
Evaluation of the Relationship Between Bruxism and Tryptophan Metabolites
|
N/A | |
Enrolling by invitation |
NCT02235220 -
Reduction of Masticatory Muscle Activity by Restoring Canine Guidance
|
N/A | |
Recruiting |
NCT05995431 -
Impact of Bruxism in the Outcome of Subgingival Instrumentation for the Management of Stage 2 and Stage 3 Periodontitis.
|
N/A | |
Recruiting |
NCT05604729 -
The Effect on Envelope of Motion in Asymptomatic Bruxers
|
N/A | |
Not yet recruiting |
NCT05764694 -
Correlation Between the Occurrence of School Bullying, Victimization, and the Occurrence of Deleterious Oral Habits.
|
||
Completed |
NCT06258070 -
Clinical Performance of Therapeutic Use of BTX for Bruxism
|
N/A | |
Completed |
NCT04363931 -
Investigation of the Effects of Kinesio Taping and Manual Therapy in Patients With Bruxism
|
N/A | |
Terminated |
NCT01005511 -
Treatment Period and Long-term Efficacy of Functional Electrical Stimulation (FES) on Sleep Bruxism
|
N/A | |
Not yet recruiting |
NCT06052709 -
Investigation of Occupational Balance in Individuals With and Without Bruxism
|
N/A | |
Recruiting |
NCT06037798 -
The Cranio-cervical Flexion Test Using the NOD Device
|
||
Recruiting |
NCT03006133 -
Prevalence of Bruxism in a Group of Preschool Egyptian Children
|
N/A | |
Completed |
NCT02257320 -
TMJ NextGeneration(TM) Feasibility Study
|
N/A | |
Completed |
NCT04884152 -
Telerehabilitation in Individuals Temporomandibular Dysfunction With Bruxism
|
N/A | |
Recruiting |
NCT04722809 -
Efficacy of Botulinum Toxin A in the Treatment of Bruxism-related Symptomatology
|
Phase 3 | |
Completed |
NCT01463826 -
Respiratory Problems and Caries in Children With Bruxism
|
N/A | |
Completed |
NCT05416788 -
Effect of Cervical Manipulation on Mouth Opening
|
N/A | |
Not yet recruiting |
NCT06386809 -
Effectiveness of Transcutaneous Auricular Vagus Nerve Stimulation in Bruxism
|
N/A | |
Recruiting |
NCT05562531 -
Botulinum Toxin Administration on Masticatory Performance
|
||
Enrolling by invitation |
NCT06377475 -
Fabrication and Insertion of Michigan Splints by Dental Students
|
||
Completed |
NCT04790110 -
7 Year Follow up Analysis on the Speed of Progression of Tooth Wear Using 3D Subtraction
|